Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash Flows From Operating Activities:
Net income	$ 7,946	$ 4,979
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and accretion	1,649	1,622
Provision for credit losses	1,660	730
Stock based compensation	559	940
Net gain on sale of securities	(50)	(431)
Net loss on sale and write down of OREO and other repossessed property	121	644
Gain on insurance proceeds	(203)	(1,180)
Earnings from investment in BOLI	(223)	(226)
Deferred tax expense	2,329	344
Proceeds from sales of mortgage loans	5,710	11,682
Mortgage loans originated for sale	(6,213)	(11,400)
Gain on sale of mortgage loans	(148)	(282)
Proceeds from sales of loans	2,403	564
Loans originated for sale	(2,250)	(525)
Gain on sale of loans	(153)	(39)
Increase in accrued interest receivable	(255)	(59)
(Increase) decrease in other assets	(405)	4,859
Increase in accrued interest payable	20	60
Increase (decrease) in other liabilities	1,899	(1,772)
Net Cash Provided By Operating Activities	14,396	10,510
Cash Flows From Investing Activities:
Activity in available-for-sale securities: Sales	3,030	43,913
Activity in available-for-sale securities: Maturities, repayments and calls	30,201	55,195
Activity in available-for-sale securities: Purchases	(30,352)	(59,646)
Activity in held-to-maturity securities: Sales	737	761
Activity in held-to-maturity securities: Maturities, repayments and calls	5,442	13,647
Activity in held-to-maturity securities: Purchases	(1,407)	(13,507)
Net cash disbursed in connection with acquisition		(5,488)
Net (increase) decrease in restricted stock	(2,260)	999
Net increase in loans	(32,453)	(29,693)
Proceeds from insurance company		1,180
Death benefit proceeds	664
Purchases of office property and equipment	(642)	(3,181)
Expenses capitalized in OREO	(15)	(1,236)
Proceeds from sale of OREO and other repossessed property	609	432
Net Cash (Used in) Provided by Investing Activities	(26,446)	3,376
Cash Flows From Financing Activities:
Net (decrease) increase in deposits	(23,984)	51,759
Repayment of FHLBP advances	(46,167)	(43,104)
Funding of FHLBP advances	69,848
Net increase (decrease) in repurchase agreements	134	(20,527)
Increase (decrease) in other borrowings	2,320	(46)
Dividends paid	(1,194)	(895)
Payment of employee taxes on stock option exercise and share award vest	(635)	(701)
Tax benefit for restricted stock vesting		188
Sale of treasury stock	542	424
Net Cash Provided By (Used In) Financing Activities	864	(12,902)
Net Change in Cash and Cash Equivalents	(11,186)	984
Cash and Cash Equivalents at Beginning of Period	22,103	21,119
Cash and Cash Equivalents at End of Period	10,917	22,103
Supplemental Disclosure of Cash Flow Information:
Cash paid during the period for: Interest	5,700	3,264
Cash paid during the period for: Income taxes	3,511	1,175
Supplemental Disclosure of Non-cash Flow Information:
Net decrease in goodwill	65
Transfers from loans to other real estate owned and other repossessed property	$ 2,960	26
Non-cash assets acquired: Investment securities		3,027
Non-cash assets acquired: Loans		306,396
Non-cash assets acquired: Goodwill		15,590
Non-cash assets acquired: Core deposit intangible		508
Non-cash assets acquired: Other assests		10,838
Total non-cash assets acquired		336,359
Non-cash liabilities assumed: Deposits		227,153
Non-cash liabilities assumed: FHLBP advances		68,436
Non-cash liabilities assumed: Other liabilities		576
Total non-cash liabilities assumed		$ 296,165